Lutein/Zeaxanthin in AREDS2 May Slow Progression to Late AMD
FRIDAY, June 10, 2022 (HealthDay News) — For individuals with age-related macular degeneration (AMD), the addition of lutein/zeaxanthin to the Age-Related Eye Disease Study 2 (AREDS2) supplement appears to be safe, according to a study published onli…
Learn MoreRAAS Inhibitors May Cut Risk for Rupture in Brain Aneurysm
FRIDAY, June 10, 2022 (HealthDay News) — Among patients with hypertension and intracranial aneurysm, renin-angiotensin-aldosterone system (RAAS) inhibitors may reduce the risk for rupture compared with other classes of antihypertensive drugs, accordi…
Learn MoreMany Localities Not Ready for Launch of 988 Mental Health Hotline
THURSDAY, June 9, 2022 (HealthDay News) — Half of jurisdictions may not be prepared for the July launch of the new national 988 emergency mental health telephone service, according to the results of a survey conducted by RAND Health Care.Jonathan H. …
Learn MorePerception of E-Cigarettes as More Harmful Increased 2019 to 2020
THURSDAY, June 9, 2022 (HealthDay News) — Between 2019 and 2020, there was an increase in the perception of electronic cigarettes as more harmful than cigarettes, according to a study published online June 8 in the American Journal of Preventive Medi…
Learn MoreFour in 10 U.S. Adults Not Comfortable Performing CPR
THURSDAY, June 9, 2022 (HealthDay News) — Six in 10 U.S. adults feel comfortable taking charge and giving cardiopulmonary resuscitation (CPR), according to the results of a survey released by the American Heart Association.The online survey was condu…
Learn MoreWHO Experts Open to Notion That China Lab Leak Spurred COVID-19
THURSDAY, June 9, 2022 (HealthDay News) — In an about-face from an original report on what might have caused the COVID-19 pandemic, experts enlisted by the World Health Organization said Thursday that they could not discount the “China lab leak” theo…
Learn MoreModerna Says Updated Vaccine Tackles Omicron
THURSDAY, June 9, 2022 (HealthDay News) — Moderna announced Wednesday that its updated COVID-19 booster shot does a better job at thwarting the omicron variant than the original version does.”We are thrilled to share the preliminary data analysis on …
Learn MoreTwo New Omicron Subvariants Gain Ground in the U.S.
THURSDAY, June 9, 2022 (HealthDay News) — The omicron subvariants BA.4 and BA.5 are spreading rapidly in the United States, but it is not yet clear if they will trigger a new wave of infections or a surge in hospitalizations and deaths, experts say.T…
Learn MoreRadiographic Findings Described for Salpingography, Recanalization
THURSDAY, June 9, 2022 (HealthDay News) — Diagnostic selective salpingography followed by fallopian tube recanalization may be a treatment option for some women with infertility, according to a study presented at the annual meeting of the Society of …
Learn MoreASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
THURSDAY, June 9, 2022 (HealthDay News) — Early research shows that overall survival is longer with ramucirumab and pembrolizumab (RP) compared with an investigator’s choice standard-of-care (SOC) in advanced non-small cell lung cancer (NSCLC), accor…
Learn More